Intouch Solutions

SEPTEMBER 13, 2023

As the world evolves at an increasing pace – technology, medical science, and more – life-sciences brands need to evolve their concept of promotional peer-to-peer medical education and what it’s capable of. It’s a mainstay of all robust life-sciences brands… Or, at least, it should be.

Branding 64

Branding Life Science Marketing Regulation 64

World of DTC Marketing

JUNE 22, 2022

Between 2019 and 2021, Alphabet’s venture-capital arms, Google Ventures, and Gradient Ventures, and its private-equity unit, CapitalG, made about 100 deals, a quarter of Alphabet’s combined total, in life sciences and health care. Generic drugs versus branded is also a considerable expense.

Pharmacy 227

Pharmacy Generic Drugs Life Science Branding 227

Pharma in Brief

MAY 4, 2023

The Ontario Superior Court ( ONSC ) has dismissed a claim for damages under section 8 of the Patented Medicines (Notice of Compliance) Regulations (the Regulations ) brought by Apotex Inc. The Court conducted a purposive interpretation of the Regulations and found that Apotex did not meet the statutory requirements for damages.

Regulation 52

Regulation Sales Production Compliance 52

Drug Discovery World

JULY 18, 2023

Chris Hughes, Managing Director North Europe, Revvity, said: “We are thrilled to be part of the UK’s life sciences industry through our Scientific Centre of Excellence and top expertise in Cambridge.

Genome 52

Genome Genomics Life Science Gene Editing 52

Pharma in Brief

NOVEMBER 20, 2023

The Courts’ decisions provide insight into how natural health products are distinguished, under federal law, from cosmetics and from drugs subject to the Food and Drug Regulations. In its August 16, 2023 decision in Le-Vel Brands, LLC v. Natural health product vs. regulated drug In Winning Combination Inc.

Production 52

Production Cosmetics Regulation Branding 52

pharmaphorum

JANUARY 10, 2023

Data is transforming life sciences, but many organisations are not using its full potential. Life sciences and the pharmaceutical industry are awash with data. The combination of health and data, he passionately believes, will transform life sciences. Capturing market share. Better customer experience.

Marketing 98

Marketing Life Science Sales Branding 98

pharmaphorum

DECEMBER 15, 2022

The Association of the British Pharmaceutical Industry (ABPI) said today that in 2023 manufacturers of branded medicines will have to return almost £3.3 of total sales – under the Voluntary Scheme for Branded Medicines Pricing and Access (VPAS) introduced in 2019. billion (around $4 billion) in revenue to the government – 26.5%

Branding 73

Branding Life Science Manufacturing Medicine 73

pharmaphorum

OCTOBER 12, 2022

Remaining compliant is imperative to the life sciences industry, so adhering to regulatory requirements is mandatory. This need for data integrity facilitates and maintains trust between the regulators and the manufacturing organisations and, in turn, patients. Both of these can ultimately deteriorate brand reputation.

Compliance 105

Compliance Manufacturing Life Science Production 105

Drug Channels

MARCH 6, 2023

Experts from across the industry will discuss how current and future drug pricing transparency regulations will impact commercialization, reimbursement, pricing and compliance practices. Plus, assess how companies are internally planning for these changes.

Drugs 98

Drugs Life Science Compliance Branding 98

FDA Law Blog

AUGUST 4, 2022

Gain insight and training in core regulatory concepts for life sciences attorneys, business executives, and policy analysts. It is important for attorneys who do not have regulatory practices and life sciences executives who deal with FDA-regulated products to have a familiarity with these concepts.

Life Science 40

Life Science Clinical Trials Clinical Trials Regulation 40

Pharma in Brief

NOVEMBER 5, 2023

For a generic or biosimilar product, the manufacturer may also apply to have the drug product designated on the Formulary as interchangeable with the original brand product. 201/96 under the Ontario Drug Benefit Act ( ODBA Regulations ). 935 under the Drug Interchangeability and Dispensing Fee Act ( DIDFA Regulations ).

Drugs 52

Drugs Regulation Production Generic Drugs 52

FDA Law Blog

MARCH 6, 2024

John counsels FDA-regulated entities on litigation, enforcement, and compliance matters including FDA inspections, Form 483s, Warning and Untitled Letters and Consent Decrees, internal investigations, and data privacy concerns. His presentation will focus on “MoCRA is Here – Now What? We can offer our readers a special discount for the event.

Cosmetics 59

Cosmetics Compliance Generic Drugs Regulation 59

pharmaphorum

APRIL 7, 2021

Originally developed with GlaxoSmithKline, ofatumumab was first approved by regulators to treat chronic lymphocytic leukaemia under the brand name Arzerra. This would also help to counter the imbalance of power in the life sciences world, which is still quite US-centric. “It

Branding 88

Branding Life Science Regulation Drugs 88

pharmaphorum

FEBRUARY 25, 2022

The past two years have shone a spotlight on the UK life sciences industry. These efforts, as Nadhim Zahawi rightly said when he was Vaccines Minister, have led to the life sciences and pharma industry becoming a UK national treasure. This increased brand recognition clearly acts as a double-edged sword.

Life Science 98

Life Science Vaccination Vaccine Pharmacy 98

Pharma in Brief

APRIL 29, 2021

The aim was to end the practice of brand name drug manufacturers covering the patients’ portion of the cost of brand name drugs in order to make them as attractive to patients and physicians as lower cost generics. Notably, the coming into force of the prohibition was suspended pending the adoption of such regulation.

Manufacturing 52

Manufacturing Drugs Regulation Branding 52

pharmaphorum

OCTOBER 19, 2022

Emma Hyland, VP strategy, commercial content at Veeva Systems, tells us modular content is the most significant wave of innovation hitting the content world in life sciences, and rightly so because HCPs’ needs and expectations have changed. “There isn’t a one-size-fits-all for how the life sciences industry creates content.

Life Science 97

Life Science Compliance Production Pharma Companies 97

XTalks

MARCH 25, 2021

Sydney writes about various food industry topics, including safety and regulation, grocery and foodservice, innovation and sustainability. She focuses on news relating to the food industry and writes blogs on recruitment and HR in the life sciences. Mira Nabulsi, MJ , is a multimedia editor and webinar moderator at Xtalks.

Life Science 95

Life Science HR Branding Production 95

XTalks

JANUARY 9, 2024

Swoop , a leader in healthcare marketing, recently introduced a groundbreaking portfolio of predictive AI targeting for pharmaceutical and life sciences advertisers. Others emphasize on ethical AI use, ensuring data privacy and compliance with healthcare regulations.

Marketing 104

Marketing Life Science Compliance Doctors 104

XTalks

SEPTEMBER 28, 2023

In most cases, commercials are regulated to ensure they provide accurate information, include the benefits and risks of the drugs and encourage viewers to talk to their healthcare providers about the medication. The US is among the few places in the world where DTC ads for health and medical products are legal; it is banned in most countries.

Drugs 105

Drugs Allergies Branding FDA Approval 105

pharmaphorum

OCTOBER 27, 2022

Companies are responsible for all content disseminated via a digital channel when the content is initiated, branded, and/or sponsored by the company or a third party acting on its behalf. Why is guidance needed? What are the key points from the Guidance? What are the rules on Social Media Influencers and Digital Opinion Leaders?

Life Science 98

Life Science Compliance Regulation Cosmetics 98

pharmaphorum

OCTOBER 3, 2022

. “TV used to be very brand-centric. The entertainment industry has also moved from brand-centric content to experiential content, designed to immerse its audience in its message by attempting to create deep emotional connections between the customer and the brand. He holds a bachelor’s degree in Pharmacy from St.

Branding 116

Branding Doctors Doctor Compliance 116

XTalks

MAY 17, 2024

The settlement requires Totality to take several specific corrective actions, which include refraining from making any statements that suggest the spa’s products are genuine, FDA-approved Lilly products, and stopping the use of Eli Lilly branding in promoting any of the products.

Sales 52

Sales FDA Approval Pharmacy Production 52

pharmaphorum

FEBRUARY 4, 2021

That’s why CIOs and CTOs working within the life sciences industry need to include Salesforce org management as a key component of their standard operating procedures. As such, many in the life sciences industry view Salesforce as more than just a CRM, and are running the entire enterprise with it.

Compliance 106

Compliance Life Science HR Development 106

Pharma in Brief

JULY 5, 2021

The Federal Court of Appeal ( FCA ) has confirmed that in an infringement action under the Patented Medicines (Notice of Compliance) Regulations , the “second person” ( i.e. , generic/biosimilar) is not precluded from pleading invalidity allegations in its Statement of Defence beyond those that were raised in its notice of allegation ( NOA ).

Regulation 52

Regulation Compliance Containment Branding 52

XTalks

MAY 21, 2021

They can give your company brand awareness when used for training sessions, educational courses or corporate events. Drive marketing and branding efforts . As employees across an organization would need to be informed of health and safety regulations. . Panel-based webinars are excellent forums for brand awareness.

Marketing 116

Marketing Branding Production Sales 116

pharmaphorum

JULY 13, 2021

The regulated content and labeling software firm has made three new customer-facing appointments and created a brand-new Customer Experience Team to provide enhanced, end-to-end customer support for medical device and clinical trial organizations.

Clinical Trials 52

Clinical Trials Clinical Trials Compliance Trials 52

pharmaphorum

APRIL 7, 2021

He also had to renegotiate a contract with GSK relating to ofatumumab – branded at that time as Arzerra. Van de Winkel acknowledges the huge challenges that the company has faced over the last year – the interview is over zoom because of COVID-19 regulations. In good shape. We are in a crisis. Role models.

Antibody 92

Antibody Life Science Development Regulation 92

pharmaphorum

JANUARY 20, 2022

Due to the rise of digital technology, it’s more important than ever for brands to strategically develop content that stands out from competitors in the crowded digital space. Pharma’s messaging, in particular, is crucial to brand awareness, acceptance, and prosperity. Every country has its regulations. About Veeva Systems .

Compliance 98

Compliance Sales Branding Marketing 98

Intouch Solutions

DECEMBER 9, 2021

But as a metaphor for your brand content, these unvisited idylls are everything you DON’T want to be. Content strategy ensures that brand claims and messages are packaged such that users actually want to see them. Life-sciences companies ought to have the most high-ranking content about health online.

Branding 52

Branding Engineer Life Science Marketing 52

Pharmaceutical Technology

NOVEMBER 29, 2022

In March 2019, the American regulator approved esketamine , an enantiomer of ketamine, for use in treatment-resistant depression as a nasal spray. The Canadian company Awakn Life Sciences is focused on the drug’s use as an treatment of conditions like alcohol use disorder and and behavioral conditions such as addiction.

Research 275

Research Trials Drugs Generic Drugs 275

Advarra

MARCH 21, 2023

Regulations for research involving devices, in vitro diagnostics (IVDs), and digital therapeutics differ from those governing pharmaceutical development. Interpreting evolving regulations for these devices is often a unique challenge for emerging biotech companies. How do you determine if clinical trials are needed for your device?

Clinical Trials 52

Clinical Trials Clinical Trials Trials Production 52

pharmaphorum

FEBRUARY 11, 2021

In each location these regulations and codes of conduct present challenges and opportunities for companies when working together with patients as collaborators in the design and conduct of trials. There’s also that risk of a perceived coercion or influence. There’s sometimes a bit of a barrier,” he added.

Clinical Trials 101

Clinical Trials Clinical Trials Trials Clinical Research 101

XTalks

MAY 16, 2024

For pharmaceutical companies, this is crucial in ensuring compliance with stringent regulations while maximizing campaign efficacy. A spokesperson from Innovid said the company believes the findings are related to “brand stories traditionally fitting into 30-second slots and, as viewers, we’ve become accustomed to that duration.”

Compliance 52

Compliance Branding Regulation Life Science 52

XTalks

JUNE 3, 2024

A 2015 article on “The Impact of Direct-to-Consumer Advertising” highlighted that physicians are not sold on the idea of DTCs, particularly because they felt the ads did not educate patients on all aspects of the drug and felt pressured to prescribe a brand name.

Marketing 52

Marketing Drugs FDA Approval Clinical Trials 52

XTalks

OCTOBER 14, 2022

GLP-1 is involved in the regulation of appetite and caloric intake. A Wegovy rival is in the works from Eli Lilly who submitted a rolling submission to the FDA for its weight loss drug tirzepatide, branded as Mounjaro. Wegovy is Novo Nordisk’s higher-dose injectable form of semaglutide repurposed for chronic weight management.

Drugs 59

Drugs Marketing Branding Sales 59

The Pharma Data

FEBRUARY 22, 2021

It will be applied broadly, fairly and in compliance with all applicable employment laws and regulations worldwide and across all management teams in Bayer.”. Bayer is a global enterprise with core competencies in the life science fields of health care and nutrition. About Bayer. billion euros. billion euros.

Life Science 52

Life Science Compliance Development Containment 52

XTalks

JANUARY 29, 2021

This is relevant for clinical trials as more regulators require evidence of efficacy in comparison to the standard of care, which is likely to be one of the blockbuster products. As more trials show equivalency in outcomes between the branded and biosimilar product, more purchasers will choose the cheaper option.

Clinical Trials 104

Clinical Trials Clinical Trials Production Trials 104